Example: stock market

Search results with tag "Aflibercept"

Eylea® (aflibercept) Injectable Medication ... - Aetna

Eylea® (aflibercept) Injectable Medication ... - Aetna

www.aetna.com

Eylea® (aflibercept) Injectable Medication Precertification Request Page 1 of 1 Aetna Precertification Notification . Phone: 1-866-752-7021. FAX: 1-888-267-3277. For Medicare Advantage Part B: (All fields must be completed and legible for Precertification Review.) Please Use Medicare Request Form . Please indicate: Start of treatment, start ...

  Aetna, Medication, Request, Precertification, Injectable medication precertification request, Injectable, Injectable medication, Aetna precertification, Aflibercept

Eylea, INN-aflibercept Assessment report Procedure No ...

Eylea, INN-aflibercept Assessment report Procedure No ...

www.ema.europa.eu

CHMP assessment report EMA/646256/2012 Page 6/83 1. Backgroundinformation on the procedure 1.1. Submission of the dossier The applicant Bayer Pharma AGsubmitted on 31 …

  Assessment, Report, Procedures, Aflibercept, Inn aflibercept assessment report procedure no

采視明 EYLEA Injection) 醫療科技評估報告

采視明 EYLEA Injection) 醫療科技評估報告

www.nhi.gov.tw

采視明 (EYLEA ® Injection) 醫療科技評估報告 (藥物納入全民健康保險給付建議書-藥品專用 ) 資料摘要. 藥品名稱 EYLEA 成分 aflibercept

  Aflibercept

Assessment report - European Medicines Agency

Assessment report - European Medicines Agency

www.ema.europa.eu

Aflibercept is a recombinant human fusion protein that acts as a high -affinity soluble decoy receptor that can block the VEGF pathway by preferentially binding to vascular endothelial growth factor A

  Assessment, Report, Assessment report, Aflibercept

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

www.ema.europa.eu

2 1. NAME OF THE MEDICINAL PRODUCT ZALTRAP 25 mg/ml concentrate for solution for infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml of concentrate for solution for infusion contains 25 mg aflibercept*.

  Aflibercept

Similar queries